Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe.
暂无分享,去创建一个
M. Woodward | G. Lowe | W. Koenig | A. Imhof | P. Amouyel | M. Fröhlich | N. Helbecque | H. Loewel
[1] K. Tang,et al. Simultaneous genotyping of seven single-nucleotide polymorphisms in the MDR1 gene by single-tube multiplex minisequencing. , 2003, Clinical chemistry.
[2] W. Koenig,et al. C-Reactive Protein Risk Prediction: Low Specificity, High Sensitivity , 2002, Annals of Internal Medicine.
[3] G. Dagenais,et al. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. , 2001, Archives of internal medicine.
[4] Natalia S. Rost,et al. Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study , 2001, Stroke.
[5] K. Kayaba,et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population : Jichi Medical School Cohort Study. , 2001, American journal of epidemiology.
[6] G. Lowe,et al. C-Reactive Protein, Fibrin D-Dimer, and Incident Ischemic Heart Disease in the Speedwell Study: Are Inflammation and Fibrin Turnover Linked in Pathogenesis? , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[7] Hermann Brenner,et al. Effect of alcohol consumption on systemic markers of inflammation , 2001, The Lancet.
[8] C. Kluft,et al. Determination of the habitual low blood level of C-reactive protein in individuals. , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.
[9] D. Rothenbacher,et al. Role of novel markers of inflammation in patients with stable coronary heart disease. , 2001, The American journal of cardiology.
[10] N Rifai,et al. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. , 2001, Clinical chemistry.
[11] W. Koenig,et al. C-Reactive protein and cardiovascular risk: has the time come for screening the general population? , 2001, Clinical chemistry.
[12] G. Lowe,et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. , 2000, The New England journal of medicine.
[13] D. Strachan,et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. , 2000, European heart journal.
[14] J. Danesh,et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.
[15] G. Lowe,et al. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. , 2000, Clinical chemistry.
[16] L. Pilotto. [Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[17] L. Bouter,et al. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[18] N Rifai,et al. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. , 1999, Clinical chemistry.
[19] A. Döring,et al. Oral contraceptive use is associated with a systemic acute phase response , 1999 .
[20] E. Barrett-Connor,et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. , 1999, Circulation.
[21] J. Manson,et al. Hormone replacement therapy and increased plasma concentration of C-reactive protein. , 1999, Circulation.
[22] C. Stehouwer,et al. Increased C-reactive Protein Levels during Short-term Hormone Replacement Therapy in Healthy Postmenopausal Women , 1999, Thrombosis and Haemostasis.
[23] A. Döring,et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.
[24] P. Ridker,et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. , 1998, Circulation.
[25] M. Pepys,et al. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. , 1998, Clinical chemistry.
[26] P. Macfarlane,et al. West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .
[27] D. Strachan,et al. C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.
[28] J. Robotham,et al. The acute-phase response. , 1995, New horizons.
[29] A. Whitehead,et al. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. , 1994, Immunology today.
[30] P. Minor,et al. WHO Expert Committee on Biological Standardization. , 2004, World Health Organization technical report series.
[31] Principal Investigators,et al. The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collabaration , 1988 .
[32] M. Kornitzer,et al. The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .
[33] The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. , 1988, Journal of clinical epidemiology.
[34] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[35] Laurent Degos,et al. HISTOCOMPATIBILITY DETERMINANTS IN MULTIPLE SCLEROSIS , 1974 .